Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$125.51 - $229.3 $393,975 - $719,772
-3,139 Reduced 18.62%
13,719 $3.02 Million
Q1 2021

Apr 27, 2021

SELL
$260.64 - $382.12 $343,523 - $503,634
-1,318 Reduced 7.25%
16,858 $5.87 Million
Q4 2020

Feb 03, 2021

SELL
$221.31 - $316.61 $1.31 Million - $1.88 Million
-5,924 Reduced 24.58%
18,176 $4.7 Million
Q2 2020

Aug 04, 2020

BUY
$123.9 - $195.41 $2.99 Million - $4.71 Million
24,100 New
24,100 $4.54 Million
Q2 2019

Jul 22, 2019

SELL
$113.99 - $146.86 $683,940 - $881,160
-6,000 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$122.82 - $151.83 $736,920 - $910,980
6,000 New
6,000 $792,000
Q3 2018

Oct 15, 2018

SELL
$152.62 - $189.66 $2.82 Million - $3.51 Million
-18,487 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$152.5 - $216.77 $2.44 Million - $3.47 Million
-16,005 Reduced 46.4%
18,487 $2.84 Million
Q1 2018

May 08, 2018

SELL
$97.41 - $177.22 $2.51 Million - $4.57 Million
-25,775 Reduced 42.77%
34,492 $5.8 Million
Q4 2017

Feb 06, 2018

BUY
$79.6 - $114.73 $1.13 Million - $1.64 Million
14,257 Added 30.99%
60,267 $5.89 Million
Q3 2017

Oct 25, 2017

BUY
$66.19 - $103.46 $3.05 Million - $4.76 Million
46,010
46,010 $4.76 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.7B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.